Concepedia

Nathalie Mouraret

NM

Statistics

Publications

5

Citations

439

H-Index

5

Active since

2012

Affiliations

Inserm(Current)

Assistance Publique – Hôpitaux de Paris

Université Paris-Est Créteil

Sorbonne Université

Nathalie Mouraret is an author at Inserm specializing in medicine, pulmonary hypertension, and pulmonary hypertension pharmacology.

Publications per year

2012–2014

5

Publications

5

Rapamycin Reverses Pulmonary Artery Smooth Muscle Cell Proliferation in Pulmonary Hypertension

Amal Houssaïni, Shariq Abid, Nathalie Mouraret et al. · American Journal of Respiratory Cell and Molecular Biology · 2013 · 147 citations

, , +10

Activation of Lung p53 by Nutlin-3a Prevents and Reverses Experimental Pulmonary Hypertension

Nathalie Mouraret, Élisabeth Marcos, Shariq Abid et al. · Circulation · 2013 · 114 citations · Full text

, , +15

CCR5 as a Treatment Target in Pulmonary Arterial Hypertension

Valérie Amsellem, Larissa Lipskaia, Shariq Abid et al. · Circulation · 2014 · 102 citations

, , +16

p21-Dependent Protective Effects of a Carbon Monoxide–Releasing Molecule-3 in Pulmonary Hypertension

Shariq Abid, Amal Houssaïni, Nathalie Mouraret et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2013 · 41 citations

, , +13

Inhibition of gut- and lung-derived serotonin attenuates pulmonary hypertension in mice

Shariq Abid, Amal Houssaïni, Caroline Chevarin et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2012 · 35 citations

, , +15

1–5 of 5